Therapy News and Research

RSS

$2 million grant to provide instrumentation, core facilities devoted to synthetic biology

The Roy J. Carver Charitable Trust has awarded a $2 million grant to the Institute for Genomic Biology at the University of Illinois at Urbana-Champaign. Under the leadership of Principal Investigator Dr. Huimin Zhao and co-Principal Investigator Dr. Christopher Rao, the grant will be disbursed over two years to provide instrumentation and core facilities for a new research theme devoted to the new scientific subdiscipline of synthetic biology.

29 May 2013

Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

In the first study of its kind in the United States, researchers at Nationwide Children's Hospital will examine the effectiveness of antibiotic therapy alone to treat appendicitis in children, research that could allow patients to avoid a surgery many may not need.

29 May 2013

Transplantation of human stem cells improves muscle function in rats used to model ALS

Transplantation of human stem cells in an experiment conducted at the University of Wisconsin-Madison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure.

29 May 2013

New test to predict increased risk of death, hospitalization among kidney dialysis patients

Johns Hopkins scientists report that a 10-minute test for "frailty" first designed to predict whether the elderly can withstand surgery and other physical stress could be useful in assessing the increased risk of death and frequent hospitalization among kidney dialysis patients of any age.

29 May 2013

LA BioMed researchers recognized for training next generation of physicians

Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their "outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching," according to the David Geffen School of Medicine at UCLA, which presented the awards.

29 May 2013

Crittenton researchers receive grant to study trauma treatment in children

Crittenton Children's Center has received a two-year, $10,000 grant from the Eye Movement Desensitization and Reprocessing Research Foundation to conduct a first of its kind study addressing trauma in children.

29 May 2013

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Acorda Therapeutics, Inc. will present new research data on AMPYRA (dalfampridine) Extended Release Tablets, 10 mg at the 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis, being held in Orlando, FL, May 29 - June 1.

28 May 2013

Asfotase alfa gets Breakthrough Therapy designation from FDA for treatment of patients with HPP

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to asfotase alfa for the treatment of patients with hypophosphatasia (HPP) whose first signs or symptoms occurred prior to 18 years of age, including perinatal-, infantile-, and juvenile-onset forms of the disease.

28 May 2013

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance.

28 May 2013

Omthera to be acquired by AstraZeneca

AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia.

28 May 2013

Human foetal stem cell therapy improves structural integrity of the spine

Human foetal stem cell grafts improve both motor and sensory functions in rats suffering from a spinal cord injury, according to research published this week in BioMed Central's open access journal Stem Cell Research and Therapy.

28 May 2013

St James's Institute of Oncology orders two Versa HD systems to improve patient care

St James's Institute of Oncology, a leading radiotherapy center in the UK, recently ordered two Versa HD™ systems, an advanced linear accelerator designed to improve patient care and treat a wide range of tumors throughout the body.

From Elekta 28 May 2013

Single injection of human neural stem cells improves acute spinal cord injuries in rats

An international team led by researchers at the University of California, San Diego School of Medicine reports that a single injection of human neural stem cells produced neuronal regeneration and improvement of function and mobility in rats impaired by an acute spinal cord injury.

28 May 2013

Boston Scientific's GUIDE DBS System gets CE Mark approval

Boston Scientific Corporation has received CE Mark approval for use of the GUIDE DBS System, the world's first deep brain stimulation visualization system.

28 May 2013

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.

27 May 2013

Mortality rates are highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million heart failure admissions over 14 years was presented by Dr David P. Kao (Denver, Colorado).

27 May 2013

Coenzyme Q10 decreases all cause mortality by half in randomized double blind trial

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress.

27 May 2013

Study examines effectiveness of VRET on agoraphobia, panic disorder

A number of studies have demonstrated the efficacy of virtual reality exposure therapy in specific phobias, but research in  seriously impaired patients with agoraphobia is lacking.

27 May 2013

OrbusNeich introduces COMBO Dual Therapy Stent

OrbusNeich today launched the world's first dual therapy stent – the COMBO Dual Therapy Stent – to address the challenges of delayed healing of the coronary artery associated with monotherapy drug eluting stents, the current standard of care for the treatment of coronary artery disease.

27 May 2013

Combination of psychotherapy with DC may improve eating disorder psychopathology, body weight

The combination of psychotherapy with dietary counseling might be a potential useful strategy to improve both eating disorder psychopathology and body weight in patients with BED.

27 May 2013

Therapy News and Research

$2 million grant to provide instrumentation, core facilities devoted to synthetic biology

Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

Transplantation of human stem cells improves muscle function in rats used to model ALS

New test to predict increased risk of death, hospitalization among kidney dialysis patients

LA BioMed researchers recognized for training next generation of physicians

Crittenton researchers receive grant to study trauma treatment in children

Research data on AMPYRA Extended Release Tablets to be presented at CMSC and ACTRIMS meeting

Asfotase alfa gets Breakthrough Therapy designation from FDA for treatment of patients with HPP

Synthetic compound derived from sea anemone toxin shows potential to treat obesity

Omthera to be acquired by AstraZeneca

Human foetal stem cell therapy improves structural integrity of the spine

St James's Institute of Oncology orders two Versa HD systems to improve patient care

Single injection of human neural stem cells improves acute spinal cord injuries in rats

Boston Scientific's GUIDE DBS System gets CE Mark approval

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

Mortality rates are highest in heart failure patients admitted in January, on Friday, and overnight

Coenzyme Q10 decreases all cause mortality by half in randomized double blind trial

Study examines effectiveness of VRET on agoraphobia, panic disorder

OrbusNeich introduces COMBO Dual Therapy Stent

Combination of psychotherapy with DC may improve eating disorder psychopathology, body weight

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News